Circulating procoagulant microparticles in patients with venous thromboembolism

Thrombosis Research

Volumn 123, Issue 5, 2009, Pages 724-726

  Ay, Cihan ^a   Freyssinet, Jean Marie ^b   Sailer, Thomas ^a   Vormittag, Rainer ^a   Pabinger, Ingrid ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Deep vein thrombosis; Microparticles; Pulmonary embolism; Thrombosis; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; VENOUS THROMBOEMBOLISM;

EID: 60449118289     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.09.005     Document Type: Article

References (23)

1. Freyssinet J.M. Cellular microparticles: what are they bad or good for?. J Thromb Haemost 1 7 (2003) 1655-1662
2. Hugel B., Martinez M.C., Kunzelmann C., and Freyssinet J.M. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 20 (2005) 22-27
3. Lynch S.F., and Ludlam C.A. Plasma microparticles and vascular disorders. Br J Haematol 137 1 (2007) 36-48
4. Ardoin S.P., Shanahan J.C., and Pisetsky D.S. The role of microparticles in inflammation and thrombosis. Scand J Immunol 66 2-3 (2007) 159-165
5. Berckmans R.J., Neiuwland R., Boing A.N., Romijn F.P., Hack C.E., and Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85 4 (2001) 639-646
6. Mann K.G. Biochemistry and physiology of blood coagulation. Thromb Haemost 82 2 (1999) 165-174
7. Sims P.J., Wiedmer T., Esmon C.T., Weiss H.J., and Shattil S.J. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 264 29 (1989) 17049-17057
8. Gilbert G.E., Sims P.J., Wiedmer T., Furie B., Furie B.C., and Shattil S.J. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 266 26 (1991) 17261-17268
9. Hoffman M., Monroe D.M., and Roberts H.R. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: a flow cytometric study. Thromb Haemost 68 1 (1992) 74-78
10. Michelson A.D., Rajasekhar D., Bednarek F.J., and Barnard M.R. Platelet and platelet-derived microparticle surface factor V/Va binding in whole blood: differences between neonates and adults. Thromb Haemost 84 4 (2000) 689-694
11. Zwaal R.F., and Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89 4 (1997) 1121-1132
12. Engelmann B., Luther T., and Muller I. Intravascular tissue factor pathway-a model for rapid initiation of coagulation within the blood vessel. Thromb Haemost 89 1 (2003) 3-8
13. Giesen P.L., Rauch U., Bohrmann B., Kling D., Roque M., Fallon J.T., et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 96 5 (1999) 2311-2315
14. Bernal-Mizrachi L., Jy W., Jimenez J.J., Pastor J., Mauro L.M., Horstman L.L., et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 145 6 (2003) 962-970
15. Mallat Z., Benamer H., Hugel B., Benessiano J., Steg P.G., Freyssinet J.M., et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101 8 (2000) 841-843
16. Chirinos J.A., Heresi G.A., Velasquez H., Jy W., Jimenez J.J., Ahn E., et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 45 9 (2005) 1467-1471
17. Dignat-George F., Camoin-Jau L., Sabatier F., Arnoux D., Anfosso F., Bardin N., et al. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost 91 4 (2004) 667-673
18. Hron G., Kollars M., Weber H., Sagaster V., Quehenberger P., Eichinger S., et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 97 1 (2007) 119-123
19. Tesselaar M.E., Romijn F.P., Van Der Linden I.K., Prins F.A., Bertina R.M., and Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost 5 3 (2007) 520-527
20. Ay C., Tengler T., Vormittag R., Simanek R., Dorda W., Vukovich T., et al. Venous thromboembolism-a manifestation of the metabolic syndrome. Haematologica 92 3 (2007) 374-380
21. Ay C., Jungbauer L.V., Sailer T., Tengler T., Koder S., Kaider A., et al. High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant. Clin Chem 53 7 (2007) 1235-1243
22. Aupeix K., Hugel B., Martin T., Bischoff P., Lill H., Pasquali J.L., et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 99 7 (1997) 1546-1554
23. Hugel B., Zobairi F., and Freyssinet J.M. Measuring circulating cell-derived microparticles. J Thromb Haemost 2 10 (2004) 1846-1847